More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Notice of layoffs went into effect this past weekend for employees at the Food and Drug Administration. Neither the FDA nor ...
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review ...
About two months ago, The Quaker Oats Company voluntarily recalled pancake and waffle mix from its brand Pearl Milling ...
Fitch joined a 37-state coalition requesting that the FDA to take action against bad actors who are endangering consumers with counterfeit weight loss drugs.
Troy Tazbaz, the outgoing director of the FDA's digital health center, is returning to Oracle as a senior vice president.
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...